Sanofi Vaccines US Inc.
Sanofi Vaccines US Inc. received $31.9M in federal prime contract obligations in the 12 months ending Oct 5, 2026, down 56.1% from $72.7M the year before, and $244.3M since FY2022. Its largest customer is the Department of Health and Human Services.
See 6 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- NCXBGGQ8YTU9
- CAGE code
- 7V915
- Headquarters
- Swiftwater, PA
- Business size
- Other Than Small Business
- Parent company
- Sanofi S a (UEI JHSBM7A72GU5)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $21.8M | $179.7M |
| Department of Defense | $9.3M | $40.8M |
| Department of Veterans Affairs | $271K | $17.7M |
| Department of State | $12K | $3.2M |
| Department of Justice | $432K | $2.8M |
| Smithsonian Institution | $40K | $131K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | $2.8M | $92.2M |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $7.4M | $75.0M |
| 325414 | Biological Product (except Diagnostic) Manufacturing | $21.4M | $74.9M |
| 493120 | Refrigerated Warehousing and Storage | $308K | $1.6M |
| 423450 | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | $17K | $690K |
| 325411 | Medicinal and Botanical Manufacturing | $0 | $9K |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| Q999 | Medical- Other | $101.6M |
| 6505 | Drugs and Biologicals | $79.3M |
| AN12 | Health R&D services; Health Care services; Applied Research | $75.0M |
| R799 | Support- management: Other | $1.6M |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | $1.4M |
| 6525 | Imaging Equipment and supplies: Medical, Dental, Veterinary | $138K |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75D30122F00001 | Department of Health and Human Services VACCINE STORAGE AND ROTATION, 2021-2026 | $1.6M | Nov 30, 2026 |
| 75A50125C00002 | Department of Health and Human Services MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE | $53.2M | Jan 31, 2027 |
| 75H71126F80051 | Department of Health and Human Services THE NATIONAL SUPPLY SERVICE CENTER (NSSC), INDIAN HEALTH SERVICES (IHS), HAS A NEED FOR A LARGE QUANTITY OF INFLUENZA VACCINES FOR ANNUAL FLU IMMUNIZATION. THIS ANNUAL PURCHASE… | $2.0M | Mar 14, 2027 |
| 75A50124F61008 | Department of Health and Human Services THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO… | $12.6M | May 21, 2027 |
| 75A50124F61009 | Department of Health and Human Services THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO… | $1.5M | May 21, 2027 |
| 75A50126F61014 | Department of Health and Human Services MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS) | $6.0M | Sep 29, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75A50126F61014 | Department of Health and Human Services MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS) | $6.0M | Sep 21, 2026 |
| 36C26126N0751 | Department of Veterans Affairs YELLOW FEVER VACCINES NDC: 49281-0915-01 | $2K | Sep 21, 2026 |
| 19AQMM26F1490 | Department of State 2026 - 2027 FLU VACCINE | $69K | Sep 17, 2026 |
| 15B21326F00000061 | Department of Justice FY2026 SANOFI STAFF AND INMATE FLU VACCINES EO 14398 | $2K | Aug 27, 2026 |
| 75F40126P00174 | Department of Health and Human Services EO-14398 - FDA FLU VACCINE IMMUNIZATION PROGRAM | $28K | Jul 30, 2026 |
| 15B61626F00000116 | Department of Justice INMATE FLU SHOTS FOR 2026 FLU SEASON | $6K | Jul 7, 2026 |
| 75H71126F80051 | Department of Health and Human Services THE NATIONAL SUPPLY SERVICE CENTER (NSSC), INDIAN HEALTH SERVICES (IHS), HAS A NEED FOR A LARGE QUANTITY OF INFLUENZA VACCINES FOR ANNUAL FLU IMMUNIZATION. THIS ANNUAL PURCHASE… | $2.0M | Jun 11, 2026 |
| 15B40626F00000180 | Department of Justice FY26 M4 SANOFI PASTEUR FLU SHOTS APR 26 | $1K | Jun 9, 2026 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.